Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban potency in patients with cirrhosis
NL-OMON26370Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of edoxaban in Cirrhosis (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Percent difference in thrombin generation capacity. Planned start Dec 2016; status: not yet recruiting.
02
Drugs
edoxaban
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on NL-OMON26370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26370.